This Small-cap Biotech Company Outperforms Pharma Giants like Lupin, Divis Lab and Sun Pharma with Multibagger Returns of 800 per cent! This Small-cap Biotech Company Outperforms Pharma Giants like Lupin, Divis Lab and Sun Pharma with Multibagger Returns of 800 per cent! The company has market cap of Rs 2,500 million (Rs 250 Crore) and Turnover (Runrate) of Rs 1,800 million (Rs 180 Crore). DSIJ Intelligence / Monday, November 4, 2024 / Article rating: 3.7
Stocks to watch: These smallcap stocks will be in focus on Thursday! Stocks to watch: These smallcap stocks will be in focus on Thursday! The following Smallcap stocks are likely to be in focus on Thursday, January 05, 2022: DSIJ Intelligence / Wednesday, January 4, 2023 / Article rating: 4.6 On Wednesday, the Sensex tanked 636 points to close at 60, 657.45, while the Nifty 50 plunged 189.60 points to close at 18,042.95.
Shares below Rs 100: Only buyers in this biotech company that soared 471 per cent in just one year! Shares below Rs 100: Only buyers in this biotech company that soared 471 per cent in just one year! Given that shares of this company soared 471 per cent in just one year, an investment of Rs 1 lakh made last year would now be worth Rs 5.7 lakh! DSIJ Intelligence / Tuesday, September 6, 2022 / Article rating: 4.0 Given that shares of this company soared 471 per cent in just one year, an investment of Rs 1 lakh made last year would now be worth Rs 5.7 lakh!
Do you own this multibagger that has jumped 480 per cent in a year? Do you own this multibagger that has jumped 480 per cent in a year? The shares of Indrayani Biotech soared to almost 5 per cent today after the company announced its results for the quarter and year that ended on March 31, 2022. DSIJ Intelligence / Tuesday, May 31, 2022 / Article rating: 5.0 The shares of Indrayani Biotech soared to almost 5 per cent today after the company announced its results for the quarter and year that ended on March 31, 2022.
Sensex, Nifty Recover Slightly Post-RBI Move; IT and Pharma Stocks Under Pressure Sensex, Nifty Recover Slightly Post-RBI Move; IT and Pharma Stocks Under Pressure
From 52-Week Low to Upper Circuit: Heavy Buying in This Penny Stock Under Re 1; Jumps... From 52-Week Low to Upper Circuit: Heavy Buying in This Penny Stock Under Re 1; Jumps... The stock gave multibagger returns of 515 per cent in 3 years and 1,125 per cent in 5...
Semiconductor Company Announces the Launch of Its Subsidiary-Cyient Semiconductors Semiconductor Company Announces the Launch of Its Subsidiary-Cyient Semiconductors The semiconductor market is valued at approximately USD 600 billion and is projected...
Rs 22,500 Crore Order Book & 700 Per cent Returns; Shipbuilding Company Signs Landmark... Rs 22,500 Crore Order Book & 700 Per cent Returns; Shipbuilding Company Signs Landmark...
Pharma Penny Stock Under Rs 60 In Focus As Company Bags Rs 16,31,72,000 Order From... Pharma Penny Stock Under Rs 60 In Focus As Company Bags Rs 16,31,72,000 Order From... The stock is up over 60 per cent from its 52-week low of Rs 35 per share.
Bruised Blue Chip Stocks: Opportunities in Temporary Setbacks Bruised Blue Chip Stocks: Opportunities in Temporary Setbacks
Understanding Momentum Funds: How Momentum Investing Works Understanding Momentum Funds: How Momentum Investing Works
Specialised Investment Fund (SIF): A New Investment Asset Class Specialised Investment Fund (SIF): A New Investment Asset Class